Previous Article | Next Article 
Infect Immun. 1990 March; 58(3): 732-739
Construction and characterization in vivo of Bordetella pertussis aroA mutants.
M Roberts,
D Maskell,
P Novotny and
G Dougan
Department of Molecular Biology, Wellcome Research Laboratories, Beckenham, Kent, England.
ABSTRACT
A DNA fragment encoding a kanamycin resistance determinant was used to insertionally inactivate the cloned aroA gene of Bordetella pertussis in Escherichia coli K-12, and a conjugative shuttle vector system based on the suicide vector pRTP1 was used to deliver the mutations from E. coli back into B. pertussis CN2992FS and BP1. The aroA mutation was introduced by allelic exchange into the chromosome of B. pertussis, resulting in otherwise isogenic parental and aroA mutant pairs. The B. pertussis aroA mutants grew well on laboratory medium supplemented with aromatic compounds but failed to grow on unsupplemented medium. The B. pertussis aroA mutants expressed the normal B. pertussis extracellular, virulence-associated proteins; inactivated, whole-cell vaccines prepared from the mutants protected mice as efficiently as vaccines made from the parent strains against intracerebral challenge with the virulent B. pertussis 18323. Live B. pertussis aroA bacteria inefficiently colonized the lungs of NIH/S mice after they were challenged with aerosol, unlike the wild-type B. pertussis organism. Mice exposed to three separate aerosols of live B. pertussis aroA bacteria were protected against lung colonization after being exposed to an aerosol containing the virulent parental B. pertussis strain. High-level antibodies against B. pertussis rapidly appeared in the sera of mice immunized by aerosol with the B. pertussis aroA strains and challenged with the virulent parent.
Infect Immun. 1990 March; 58(3): 732-739
This article has been cited by other articles:
-
Mann, P., Goebel, E., Barbarich, J., Pilione, M., Kennett, M., Harvill, E.
(2007). Use of a Genetically Defined Double Mutant Strain of Bordetella bronchiseptica Lacking Adenylate Cyclase and Type III Secretion as a Live Vaccine. Infect. Immun.
75: 3665-3672
[Abstract]
[Full Text]
-
Buzzola, F. R., Barbagelata, M. S., Caccuri, R. L., Sordelli, D. O.
(2006). Attenuation and Persistence of and Ability To Induce Protective Immunity to a Staphylococcus aureus aroA Mutant in Mice.. Infect. Immun.
74: 3498-3506
[Abstract]
[Full Text]
-
Stritzker, J., Janda, J., Schoen, C., Taupp, M., Pilgrim, S., Gentschev, I., Schreier, P., Geginat, G., Goebel, W.
(2004). Growth, Virulence, and Immunogenicity of Listeria monocytogenes aro Mutants. Infect. Immun.
72: 5622-5629
[Abstract]
[Full Text]
-
Atkins, T., Prior, R. G., Mack, K., Russell, P., Nelson, M., Oyston, P. C. F., Dougan, G., Titball, R. W.
(2002). A Mutant of Burkholderia pseudomallei, Auxotrophic in the Branched Chain Amino Acid Biosynthetic Pathway, Is Attenuated and Protective in a Murine Model of Melioidosis. Infect. Immun.
70: 5290-5294
[Abstract]
[Full Text]
-
Hondalus, M. K., Bardarov, S., Russell, R., Chan, J., Jacobs, W. R. Jr., Bloom, B. R.
(2000). Attenuation of and Protection Induced by a Leucine Auxotroph of Mycobacterium tuberculosis. Infect. Immun.
68: 2888-2898
[Abstract]
[Full Text]
-
Hernanz Moral, C., del Castillo, E. F., Fierro, P. L., Cortes, A. V., Castillo, J. A., Soriano, A. C., Salazar, M. S., Peralta, B. R., Carrasco, G. N.
(1998). Molecular Characterization of the Aeromonas hydrophila aroA Gene and Potential Use of an Auxotrophic aroA Mutant as a Live Attenuated Vaccine. Infect. Immun.
66: 1813-1821
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.